BLENREP subst seche 100 mg 1 pce
7680699100026
Pharmacode 1138132
CH-69910
L01FX15
07.16.1.
1 / 2
google
Details
- GTIN
- 7680699100026
- Pharmacode
- 1138132
- Product number
- 6991002
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: belantamabum mafodotinum 100 mg, trinatrii citras dihydricus, acidum citricum monohydricum, trehalosum dihydricum, dinatrii edetas, polysorbatum 80, pro vitro corresp. natrium 3.15 mg.
Articles (1)
Blenrep 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
belantamabum mafodotinum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
trinatrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrium
|
3.15 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 69910
- Drug name
- Blenrep, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FX15
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/06/2025
- Authorization expiration date
- 18/06/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BLENREP subst seche 100 mg 1 pce
- Description (DE)
- BLENREP Trockensub 100 mg 1 Stk
- Market launch
- 01/09/2025
- Narcotic (BTM)
- No